Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 17 entries
Sorted by: Best Match Show Resources per page
An Interoperability Platform Enabling Reuse of Electronic Health Records for Signal Verification Studies.

BioMed research international

Yuksel M, Gonul S, Laleci Erturkmen GB, Sinaci AA, Invernizzi P, Facchinetti S, Migliavacca A, Bergvall T, Depraetere K, De Roo J.
PMID: 27123451
Biomed Res Int. 2016;2016:6741418. doi: 10.1155/2016/6741418. Epub 2016 Mar 31.

Depending mostly on voluntarily sent spontaneous reports, pharmacovigilance studies are hampered by low quantity and quality of patient data. Our objective is to improve postmarket safety studies by enabling safety analysts to seamlessly access a wide range of EHR...

Cite
Yuksel M, Gonul S, Laleci Erturkmen GB, et al. An Interoperability Platform Enabling Reuse of Electronic Health Records for Signal Verification Studies. Biomed Res Int. 2016;2016:6741418doi: 10.1155/2016/6741418.
Yuksel, M., Gonul, S., Laleci Erturkmen, G. B., Sinaci, A. A., Invernizzi, P., Facchinetti, S., Migliavacca, A., Bergvall, T., Depraetere, K., & De Roo, J. (2016). An Interoperability Platform Enabling Reuse of Electronic Health Records for Signal Verification Studies. BioMed research international, 20166741418. https://doi.org/10.1155/2016/6741418
Yuksel, Mustafa, et al. "An Interoperability Platform Enabling Reuse of Electronic Health Records for Signal Verification Studies." BioMed research international vol. 2016 (2016): 6741418. doi: https://doi.org/10.1155/2016/6741418
Yuksel M, Gonul S, Laleci Erturkmen GB, Sinaci AA, Invernizzi P, Facchinetti S, Migliavacca A, Bergvall T, Depraetere K, De Roo J. An Interoperability Platform Enabling Reuse of Electronic Health Records for Signal Verification Studies. Biomed Res Int. 2016;2016:6741418. doi: 10.1155/2016/6741418. Epub 2016 Mar 31. PMID: 27123451; PMCID: PMC4830705.
Copy Download .nbib Format: NLM
N-Confused Calix.

Angewandte Chemie (International ed. in English)

Depraetere S, Smet M, Dehaen W.
PMID: 10602194
Angew Chem Int Ed Engl. 1999 Nov 15;38(22):3359-3361. doi: 10.1002/(sici)1521-3773(19991115)38:22<3359::aid-anie3359>3.0.co;2-k.

Next to the "normal" calix[4]pyrrole 1, the N-confused calix[4]pyrrole 2 is formed in substantial amounts (up to 22 % yield) as side product in the acid-catalyzed condensation reaction of ketones and pyrrole. In some cases, doubly N-confused calix[4]pyrroles are...

Cite
Depraetere S, Smet M, Dehaen W. N-Confused Calix. Angew Chem Int Ed Engl. 1999;38(22):3359-3361doi: 10.1002/(sici)1521-3773(19991115)38:22<3359::aid-anie3359>3.0.co;2-k.
Depraetere, S., Smet, M., & Dehaen, W. (1999). N-Confused Calix. Angewandte Chemie (International ed. in English), 38(22), 3359-3361. https://doi.org/10.1002/(sici)1521-3773(19991115)38:22<3359::aid-anie3359>3.0.co;2-k
Depraetere, et al. "N-Confused Calix." Angewandte Chemie (International ed. in English) vol. 38,22 (1999): 3359-3361. doi: https://doi.org/10.1002/(sici)1521-3773(19991115)38:22<3359::aid-anie3359>3.0.co;2-k
Depraetere S, Smet M, Dehaen W. N-Confused Calix. Angew Chem Int Ed Engl. 1999 Nov 15;38(22):3359-3361. doi: 10.1002/(sici)1521-3773(19991115)38:22<3359::aid-anie3359>3.0.co;2-k. PMID: 10602194.
Copy Download .nbib Format: NLM
Pipeline analysis of a vaccine candidate portfolio for diseases of poverty using the Portfolio-To-Impact modelling tool.

F1000Research

Gunn A, Bandara S, Yamey G, D Alessio F, Depraetere H, Houard S, Viebig NK, Jungbluth S.
PMID: 32148758
F1000Res. 2019 Jul 11;8:1066. doi: 10.12688/f1000research.19810.1. eCollection 2019.

No abstract available.

Cite
Gunn A, Bandara S, Yamey G, et al. Pipeline analysis of a vaccine candidate portfolio for diseases of poverty using the Portfolio-To-Impact modelling tool. F1000Res. 2019;8:1066doi: 10.12688/f1000research.19810.1.
Gunn, A., Bandara, S., Yamey, G., D Alessio, F., Depraetere, H., Houard, S., Viebig, N. K., & Jungbluth, S. (2019). Pipeline analysis of a vaccine candidate portfolio for diseases of poverty using the Portfolio-To-Impact modelling tool. F1000Research, 81066. https://doi.org/10.12688/f1000research.19810.1
Gunn, Alexander, et al. "Pipeline analysis of a vaccine candidate portfolio for diseases of poverty using the Portfolio-To-Impact modelling tool." F1000Research vol. 8 (2019): 1066. doi: https://doi.org/10.12688/f1000research.19810.1
Gunn A, Bandara S, Yamey G, D Alessio F, Depraetere H, Houard S, Viebig NK, Jungbluth S. Pipeline analysis of a vaccine candidate portfolio for diseases of poverty using the Portfolio-To-Impact modelling tool. F1000Res. 2019 Jul 11;8:1066. doi: 10.12688/f1000research.19810.1. eCollection 2019. PMID: 32148758; PMCID: PMC7043114.
Copy Download .nbib Format: NLM
Evolving Bioprosthetic Tissue Calcification Can Be Quantified Using Serial Multislice CT Scanning.

International journal of biomaterials

Meuris B, De Praetere H, Coudyzer W, Flameng W.
PMID: 24089616
Int J Biomater. 2013;2013:617329. doi: 10.1155/2013/617329. Epub 2013 Sep 08.

Background. We investigated the value of serial multislice CT scanning for in vivo determination of evolving tissue calcification in three separate experimental settings. Materials and Methods. Bioprosthetic valve tissue was implanted in three different conditions: (1) glutaraldehyde-fixed porcine stentless...

Cite
Meuris B, De Praetere H, Coudyzer W, et al. Evolving Bioprosthetic Tissue Calcification Can Be Quantified Using Serial Multislice CT Scanning. Int J Biomater. 2013;2013:617329doi: 10.1155/2013/617329.
Meuris, B., De Praetere, H., Coudyzer, W., & Flameng, W. (2013). Evolving Bioprosthetic Tissue Calcification Can Be Quantified Using Serial Multislice CT Scanning. International journal of biomaterials, 2013617329. https://doi.org/10.1155/2013/617329
Meuris, B, et al. "Evolving Bioprosthetic Tissue Calcification Can Be Quantified Using Serial Multislice CT Scanning." International journal of biomaterials vol. 2013 (2013): 617329. doi: https://doi.org/10.1155/2013/617329
Meuris B, De Praetere H, Coudyzer W, Flameng W. Evolving Bioprosthetic Tissue Calcification Can Be Quantified Using Serial Multislice CT Scanning. Int J Biomater. 2013;2013:617329. doi: 10.1155/2013/617329. Epub 2013 Sep 08. PMID: 24089616; PMCID: PMC3782140.
Copy Download .nbib Format: NLM
Distinct sequences of the glycoprotein Ib-binding domain of von Willebrand factor involved in shear induced platelet aggregation.

Platelets

Ajzenberg N, Depraetere H, Lacombe C, Deckmyn H, Baruch D.
PMID: 16793693
Platelets. 1998;9(3):151-3. doi: 10.1080/09537109876609.

Shear-induced platelet aggregation (SIPA) requires von Willebrand factor (vWF) binding to the platelet receptors GPIb and alphaIIbbeta3. In order to determine the vW F sequences involved in SIPA at 4000/s, we studied the llb 3 effect of three monoclonal...

Cite
Ajzenberg N, Depraetere H, Lacombe C, et al. Distinct sequences of the glycoprotein Ib-binding domain of von Willebrand factor involved in shear induced platelet aggregation. Platelets. 1998;9(3):151-3doi: 10.1080/09537109876609.
Ajzenberg, N., Depraetere, H., Lacombe, C., Deckmyn, H., & Baruch, D. (1998). Distinct sequences of the glycoprotein Ib-binding domain of von Willebrand factor involved in shear induced platelet aggregation. Platelets, 9(3), 151-3. https://doi.org/10.1080/09537109876609
Ajzenberg, N, et al. "Distinct sequences of the glycoprotein Ib-binding domain of von Willebrand factor involved in shear induced platelet aggregation." Platelets vol. 9,3 (1998): 151-3. doi: https://doi.org/10.1080/09537109876609
Ajzenberg N, Depraetere H, Lacombe C, Deckmyn H, Baruch D. Distinct sequences of the glycoprotein Ib-binding domain of von Willebrand factor involved in shear induced platelet aggregation. Platelets. 1998;9(3):151-3. doi: 10.1080/09537109876609. PMID: 16793693.
Copy Download .nbib Format: NLM
Controlled Human Infection Studies: Proposals for guidance on how to design, develop and produce a challenge strain.

Biologicals : journal of the International Association of Biological Standardization

Bekeredjian-Ding I, Trouvin JH, Depraetere H, La C, Suvarnapunya AE, Bell A, Mann A, Meij P, Bethony JM, Schellhaas L, Nazziwa WB, Karikari-Boateng E, Prachumsri JS, Salmikangas P, Smith D, Stjärnkvist P, Van Molle W, Baay M, Neels P.
PMID: 34620540
Biologicals. 2021 Nov;74:16-23. doi: 10.1016/j.biologicals.2021.09.002. Epub 2021 Oct 05.

There is an increasing need to establish quality principles for designing, developing and manufacturing challenge agents as currently these agents are classified differently by various jurisdictions. Indeed, considerations for challenge agent manufacturing vary between countries due to differences in...

Cite
Bekeredjian-Ding I, Trouvin JH, Depraetere H, et al. Controlled Human Infection Studies: Proposals for guidance on how to design, develop and produce a challenge strain. Biologicals. 2021;74:16-23doi: 10.1016/j.biologicals.2021.09.002.
Bekeredjian-Ding, I., Trouvin, J. H., Depraetere, H., La, C., Suvarnapunya, A. E., Bell, A., Mann, A., Meij, P., Bethony, J. M., Schellhaas, L., Nazziwa, W. B., Karikari-Boateng, E., Prachumsri, J. S., Salmikangas, P., Smith, D., Stjärnkvist, P., Van Molle, W., Baay, M., & Neels, P. (2021). Controlled Human Infection Studies: Proposals for guidance on how to design, develop and produce a challenge strain. Biologicals : journal of the International Association of Biological Standardization, 7416-23. https://doi.org/10.1016/j.biologicals.2021.09.002
Bekeredjian-Ding, Isabelle, et al. "Controlled Human Infection Studies: Proposals for guidance on how to design, develop and produce a challenge strain." Biologicals : journal of the International Association of Biological Standardization vol. 74 (2021): 16-23. doi: https://doi.org/10.1016/j.biologicals.2021.09.002
Bekeredjian-Ding I, Trouvin JH, Depraetere H, La C, Suvarnapunya AE, Bell A, Mann A, Meij P, Bethony JM, Schellhaas L, Nazziwa WB, Karikari-Boateng E, Prachumsri JS, Salmikangas P, Smith D, Stjärnkvist P, Van Molle W, Baay M, Neels P. Controlled Human Infection Studies: Proposals for guidance on how to design, develop and produce a challenge strain. Biologicals. 2021 Nov;74:16-23. doi: 10.1016/j.biologicals.2021.09.002. Epub 2021 Oct 05. PMID: 34620540.
Copy Download .nbib Format: NLM
Fas .

Current biology : CB

Depraetere V.
PMID: 9778538
Curr Biol. 1998 Oct 08;8(20):R704. doi: 10.1016/s0960-9822(98)70452-x.

No abstract available.

Cite
Depraetere V. Fas . Curr Biol. 1998;8(20):R704doi: 10.1016/s0960-9822(98)70452-x.
Depraetere, V. (1998). Fas . Current biology : CB, 8(20), R704. https://doi.org/10.1016/s0960-9822(98)70452-x
Depraetere. "Fas ." Current biology : CB vol. 8,20 (1998): R704. doi: https://doi.org/10.1016/s0960-9822(98)70452-x
Depraetere V. Fas . Curr Biol. 1998 Oct 08;8(20):R704. doi: 10.1016/s0960-9822(98)70452-x. PMID: 9778538.
Copy Download .nbib Format: NLM
Starting an aortic valve repair program: is it worthwhile? Aortic valve repair compared to replacement.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery

Meuris B, Vervoort D, De Praetere H, Rex S, Van De Bruaene A, Herijgers P, Rega F, Verbrugghe P.
PMID: 34021336
Eur J Cardiothorac Surg. 2021 Dec 01;60(6):1369-1377. doi: 10.1093/ejcts/ezab200.

OBJECTIVES: Increasing evidence suggests that aortic valve (AV) repair may have better long-term outcomes than AV replacement for aortic insufficiency. However, most literature is limited to centres of excellence and has not sufficiently been replicated in nascent programs. This...

Cite
Meuris B, Vervoort D, De Praetere H, et al. Starting an aortic valve repair program: is it worthwhile? Aortic valve repair compared to replacement. Eur J Cardiothorac Surg. 2021;60(6):1369-1377doi: 10.1093/ejcts/ezab200.
Meuris, B., Vervoort, D., De Praetere, H., Rex, S., Van De Bruaene, A., Herijgers, P., Rega, F., & Verbrugghe, P. (2021). Starting an aortic valve repair program: is it worthwhile? Aortic valve repair compared to replacement. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 60(6), 1369-1377. https://doi.org/10.1093/ejcts/ezab200
Meuris, Bart, et al. "Starting an aortic valve repair program: is it worthwhile? Aortic valve repair compared to replacement." European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery vol. 60,6 (2021): 1369-1377. doi: https://doi.org/10.1093/ejcts/ezab200
Meuris B, Vervoort D, De Praetere H, Rex S, Van De Bruaene A, Herijgers P, Rega F, Verbrugghe P. Starting an aortic valve repair program: is it worthwhile? Aortic valve repair compared to replacement. Eur J Cardiothorac Surg. 2021 Dec 01;60(6):1369-1377. doi: 10.1093/ejcts/ezab200. PMID: 34021336.
Copy Download .nbib Format: NLM
Origins of antigenic peptides.

Nature cell biology

Depraetere V.
PMID: 10806488
Nat Cell Biol. 2000 May;2(5):E75. doi: 10.1038/35010504.

No abstract available.

Cite
Depraetere V. Origins of antigenic peptides. Nat Cell Biol. 2000;2(5):E75doi: 10.1038/35010504.
Depraetere, V. (2000). Origins of antigenic peptides. Nature cell biology, 2(5), E75. https://doi.org/10.1038/35010504
Depraetere. "Origins of antigenic peptides." Nature cell biology vol. 2,5 (2000): E75. doi: https://doi.org/10.1038/35010504
Depraetere V. Origins of antigenic peptides. Nat Cell Biol. 2000 May;2(5):E75. doi: 10.1038/35010504. PMID: 10806488.
Copy Download .nbib Format: NLM
Functional performance and quality of life in high-risk comorbid patients undergoing transcatheter aortic valve implantation for symptomatic aortic valve stenosis.

European heart journal. Quality of care & clinical outcomes

Hiltrop N, Belmans A, Claes M, Hornikx M, Peeters B, Flamaing J, Adriaenssens T, De Praetere H, Herregods MC, Herijgers P, Dubois C.
PMID: 29474610
Eur Heart J Qual Care Clin Outcomes. 2016 Jul 01;2(3):184-192. doi: 10.1093/ehjqcco/qcw001.

AIMS: We assessed the impact of transcatheter aortic valve implantation (TAVI) on functional performance and quality of life (QoL) in a high-risk patient population with multiple comorbidities.METHODS AND RESULTS: Between January 2009 and December 2014, 145 high-risk patients (EuroSCORE...

Cite
Hiltrop N, Belmans A, Claes M, et al. Functional performance and quality of life in high-risk comorbid patients undergoing transcatheter aortic valve implantation for symptomatic aortic valve stenosis. Eur Heart J Qual Care Clin Outcomes. 2016;2(3):184-192doi: 10.1093/ehjqcco/qcw001.
Hiltrop, N., Belmans, A., Claes, M., Hornikx, M., Peeters, B., Flamaing, J., Adriaenssens, T., De Praetere, H., Herregods, M. C., Herijgers, P., & Dubois, C. (2016). Functional performance and quality of life in high-risk comorbid patients undergoing transcatheter aortic valve implantation for symptomatic aortic valve stenosis. European heart journal. Quality of care & clinical outcomes, 2(3), 184-192. https://doi.org/10.1093/ehjqcco/qcw001
Hiltrop, Nick, et al. "Functional performance and quality of life in high-risk comorbid patients undergoing transcatheter aortic valve implantation for symptomatic aortic valve stenosis." European heart journal. Quality of care & clinical outcomes vol. 2,3 (2016): 184-192. doi: https://doi.org/10.1093/ehjqcco/qcw001
Hiltrop N, Belmans A, Claes M, Hornikx M, Peeters B, Flamaing J, Adriaenssens T, De Praetere H, Herregods MC, Herijgers P, Dubois C. Functional performance and quality of life in high-risk comorbid patients undergoing transcatheter aortic valve implantation for symptomatic aortic valve stenosis. Eur Heart J Qual Care Clin Outcomes. 2016 Jul 01;2(3):184-192. doi: 10.1093/ehjqcco/qcw001. PMID: 29474610.
Copy Download .nbib Format: NLM
Erratum to: Subacute onset Hirayama disease with extensive myelopathy on MRI in flexed posture.

Acta neurologica Belgica

Brems M, Van Goethem J, De Praeter M, Willekens B.
PMID: 28528468
Acta Neurol Belg. 2017 Sep;117(3):799-801. doi: 10.1007/s13760-017-0789-4.

No abstract available.

Cite
Brems M, Van Goethem J, De Praeter M, et al. Erratum to: Subacute onset Hirayama disease with extensive myelopathy on MRI in flexed posture. Acta Neurol Belg. 2017;117(3):799-801doi: 10.1007/s13760-017-0789-4.
Brems, M., Van Goethem, J., De Praeter, M., & Willekens, B. (2017). Erratum to: Subacute onset Hirayama disease with extensive myelopathy on MRI in flexed posture. Acta neurologica Belgica, 117(3), 799-801. https://doi.org/10.1007/s13760-017-0789-4
Brems, Merel, et al. "Erratum to: Subacute onset Hirayama disease with extensive myelopathy on MRI in flexed posture." Acta neurologica Belgica vol. 117,3 (2017): 799-801. doi: https://doi.org/10.1007/s13760-017-0789-4
Brems M, Van Goethem J, De Praeter M, Willekens B. Erratum to: Subacute onset Hirayama disease with extensive myelopathy on MRI in flexed posture. Acta Neurol Belg. 2017 Sep;117(3):799-801. doi: 10.1007/s13760-017-0789-4. PMID: 28528468.
Copy Download .nbib Format: NLM
Safe implementation of robotic-assisted minimally invasive direct coronary artery bypass: application of learning curves and cumulative sum analysis.

Journal of thoracic disease

Van den Eynde J, Vaesen Bentein H, Decaluwé T, De Praetere H, Wertan MC, Sutter FP, Balkhy HH, Oosterlinck W.
PMID: 34422354
J Thorac Dis. 2021 Jul;13(7):4260-4270. doi: 10.21037/jtd-21-775.

BACKGROUND: Learning curves are inevitably encountered when first implementing an innovative and complex surgical technique. Nevertheless, a cluster of failures or complications should be detected early, but not deter learning, to ensure safe implementation. Here, we aimed to examine...

Cite
Van den Eynde J, Vaesen Bentein H, Decaluwé T, et al. Safe implementation of robotic-assisted minimally invasive direct coronary artery bypass: application of learning curves and cumulative sum analysis. J Thorac Dis. 2021;13(7):4260-4270doi: 10.21037/jtd-21-775.
Van den Eynde, J., Vaesen Bentein, H., Decaluwé, T., De Praetere, H., Wertan, M. C., Sutter, F. P., Balkhy, H. H., & Oosterlinck, W. (2021). Safe implementation of robotic-assisted minimally invasive direct coronary artery bypass: application of learning curves and cumulative sum analysis. Journal of thoracic disease, 13(7), 4260-4270. https://doi.org/10.21037/jtd-21-775
Van den Eynde, Jef, et al. "Safe implementation of robotic-assisted minimally invasive direct coronary artery bypass: application of learning curves and cumulative sum analysis." Journal of thoracic disease vol. 13,7 (2021): 4260-4270. doi: https://doi.org/10.21037/jtd-21-775
Van den Eynde J, Vaesen Bentein H, Decaluwé T, De Praetere H, Wertan MC, Sutter FP, Balkhy HH, Oosterlinck W. Safe implementation of robotic-assisted minimally invasive direct coronary artery bypass: application of learning curves and cumulative sum analysis. J Thorac Dis. 2021 Jul;13(7):4260-4270. doi: 10.21037/jtd-21-775. PMID: 34422354; PMCID: PMC8339757.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 17 entries